US Broker Ratings

STERIS plc (STE) Stock Analysis: Navigating a 26% Potential Upside in Healthcare Innovation

STERIS plc (NYSE: STE), a leader in the healthcare sector focusing on infection prevention solutions, presents a compelling opportunity for investors, particularly with a substantial potential upside of 26.17%. With..

Viatris Inc. (VTRS) Stock Analysis: Exploring a 10.23% Potential Upside for Investors

Investors eyeing opportunities within the healthcare sector may find Viatris Inc. (VTRS) an intriguing prospect, particularly given its current valuation and analyst projections. With a market capitalization of $20.22 billion,..

AptarGroup, Inc. (ATR) Stock Analysis: Potential 41.89% Upside with Strong Buy Ratings

AptarGroup, Inc. (NYSE: ATR), a key player in the healthcare sector, offers investors a compelling opportunity with its robust market position and potential for significant upside. With a market capitalization..

Revvity, Inc. (RVTY) Stock Analysis: Navigating a Healthcare Giant’s Potential Amidst Mixed Ratings

Revvity, Inc. (NYSE: RVTY) has emerged as a notable player within the healthcare sector, specifically in diagnostics and research. With a robust market capitalization of $16.91 billion, the company stands..

Elanco Animal Health (ELAN) Stock Analysis: Potential 40% Upside Captivates Investor Interest

For investors with an eye on the healthcare sector, Elanco Animal Health Incorporated (NYSE: ELAN) offers a compelling investment opportunity in the drug manufacturing space, particularly for those interested in..

Globus Medical, Inc. (GMED) Stock Analysis: A Promising 33.50% Upside in the Healthcare Sector

Globus Medical, Inc. (NYSE: GMED), a key player in the healthcare sector specializing in medical devices, presents a compelling investment opportunity with a potential upside of 33.50%. With its market..

Quest Diagnostics (DGX) Stock Report: Evaluating a Potential 6.17% Upside in the Diagnostics Giant

As investors continue to navigate the ever-evolving landscape of the healthcare sector, Quest Diagnostics Incorporated (NYSE: DGX) stands out as a key player in diagnostics and research. With a market..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 43.56% Upside Potential

Align Technology, Inc. (NASDAQ: ALGN), a trailblazer in the healthcare sector with its cutting-edge dental solutions, presents a compelling opportunity for investors with its potential upside of 43.56%. As a..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Exploring an 8.51% Potential Upside for Investors

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, is a name synonymous with innovation and resilience in the global pharmaceutical industry. With its headquarters in..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: A 21.84% Upside Potential Awakens Investor Interest

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a distinguished name in the medical devices industry, is capturing investor attention with its promising upside potential of 21.84%, reflecting the company’s resilient strategies..

Natera, Inc. (NTRA) Stock Analysis: Navigating High Growth in the Diagnostics Sector

Natera, Inc. (NTRA), a notable player in the healthcare sector, specifically within Diagnostics & Research, has been capturing investor attention with its robust growth trajectory. Headquartered in Austin, Texas, Natera..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: A 45% Upside Potential Awaits Investors

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) stands tall in the healthcare sector as a significant player in the specialty and generic drug manufacturing industry. With a robust market capitalization of $14.55..

UnitedHealth Group (UNH) Stock Analysis: Exploring a 29.53% Potential Upside

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, offers investors a compelling opportunity with a potential upside of 29.53%. With a market cap of $333.82 billion, UnitedHealth..

Insmed Incorporated (INSM) Stock Analysis: A Biotech with an Impressive 77.95% Potential Upside

Insmed Incorporated (NASDAQ: INSM) is making waves in the biotechnology sector, boasting a remarkable market cap of $24.27 billion. Focused on developing therapies for serious and rare diseases, this U.S.-based..

Veeva Systems Inc. (VEEV) Stock Analysis: Robust Growth in Healthcare Tech Signals Promising Upside

Veeva Systems Inc. (NYSE: VEEV), a leader in cloud-based solutions for the life sciences industry, continues to capture investor attention with its impressive market presence and consistent growth trajectory. With..

Cardinal Health, Inc. (CAH)

⚠️ No article content returned.

..

Medtronic plc. (MDT) Investor Outlook: Exploring a 21.36% Potential Upside in a Dominant Healthcare Player

Medtronic plc (NYSE: MDT), a stalwart in the healthcare sector and a leader in the medical devices industry, is drawing investor attention with its solid performance metrics and an attractive..

Bristol-Myers Squibb (BMY): Investor Outlook on Its Strong Dividend Yield and Growth Prospects

Bristol-Myers Squibb Company (NYSE: BMY) stands as a formidable player in the healthcare sector, specifically within the general drug manufacturing industry. With a market capitalization of $124.91 billion, this biopharmaceutical..

CVS Health Corporation (CVS) Stock Analysis: Evaluating a 34% Upside Potential and Robust Analyst Confidence

CVS Health Corporation (NYSE: CVS), a stalwart in the healthcare sector, presents an intriguing proposition for investors seeking both stability and significant growth potential. With a market capitalization of $110.58..

Medpace Holdings, Inc. (MEDP)

⚠️ No article content returned.

..
Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds